Abstract
The present review discusses the synthetic strategies of new ligands exhibiting mainly 5-HT1A binding affinities. Specifically we focused our attention in the synthesis of compounds structurally related to arylpiperazine, 2-aminotetralin, and benzopyran derivatives.
Keywords: ligands, arylpiperazines, aminotetralins, benzopyrans
Mini-Reviews in Medicinal Chemistry
Title: A Synthetic Overview of New Molecules with 5-HT1A Binding Affinities
Volume: 3 Issue: 2
Author(s): Hernan Pessoa-Mahana, Ramiro Araya-Maturana, B. Claudio Saitz and C. David Pessoa-Mahana
Affiliation:
Keywords: ligands, arylpiperazines, aminotetralins, benzopyrans
Abstract: The present review discusses the synthetic strategies of new ligands exhibiting mainly 5-HT1A binding affinities. Specifically we focused our attention in the synthesis of compounds structurally related to arylpiperazine, 2-aminotetralin, and benzopyran derivatives.
Export Options
About this article
Cite this article as:
Pessoa-Mahana Hernan, Araya-Maturana Ramiro, Saitz Claudio B. and Pessoa-Mahana David C., A Synthetic Overview of New Molecules with 5-HT1A Binding Affinities, Mini-Reviews in Medicinal Chemistry 2003; 3 (2) . https://dx.doi.org/10.2174/1389557033405278
DOI https://dx.doi.org/10.2174/1389557033405278 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Plant Defensins and Defensin-Like Peptides - Biological Activities and Biotechnological Applications
Current Pharmaceutical Design Increased Paternal Age and Child Health and Development
Current Pediatric Reviews Cancer Chemopreventive Agents Discovered by Activity-Guided Fractionation: An Update
Current Organic Chemistry Recent Advances in PUVA Photochemotherapy and PDT for the Treatment of Cancer
Current Pharmaceutical Design Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments
Recent Patents on CNS Drug Discovery (Discontinued) Oxidative Stress and Skeletal Muscle Dysfunction with Aging
Current Aging Science Recent Advances in the Treatment of Neurogenic Erectile Dysfunction
Recent Patents on CNS Drug Discovery (Discontinued) Dutasteride in Androgenetic Alopecia: An Update
Current Clinical Pharmacology Hospital-Based Tobacco Interventions in Pediatric Settings
Current Pediatric Reviews A Comprehensive Review on Pharmacognostical Investigation and Pharmacology of Typhonium trilobatum
The Natural Products Journal Meet Our Editorial Board Member
Current Psychiatry Reviews Structural and Functional MRI in Mild Cognitive Impairment
Current Alzheimer Research Advanced Membrane Systems for Tissue Engineering
Current Organic Chemistry The Effect of Liver Cirrhosis on the Regulation and Expression of Drug Metabolizing Enzymes
Current Drug Metabolism Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds
Current Medicinal Chemistry Meet Our Editorial Board Member
Current Molecular Pharmacology Modulation of Cytokine Network in the Comorbidity of Schizophrenia and Tuberculosis
Current Topics in Medicinal Chemistry Intervertebral Disc and Nucleus Replacement Devices and Instrumentations
Recent Patents on Biomedical Engineering (Discontinued) The Digenea Parasite Opisthorchis felineus: A Target for the Discovery and Development of Novel Drugs
Infectious Disorders - Drug Targets 4-Hydroxynonenal in the Pathogenesis and Progression of Human Diseases
Current Medicinal Chemistry